Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
DIETA-MICIREUM
1 other identifier
observational
90
1 country
4
Brief Summary
The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting funding response) and represents the continuation of an observational clinical study named TRANSMIC, approved by the pediatric ethics committee of the Tuscany region. TRANSMIC was an integral part of a European research project within the joint programming initiative (JPI), under the HDHL-INTIMIC theme: "A Healthy Diet for a Healthy Life," aimed at understanding the cause-effect relationships between diet, gut microbiome, and human health. Understanding the role of diet in inflammatory bowel diseases (IBD) and exploring its role in autoimmune inflammatory conditions with joint manifestations, such as JIA, provides additional insights into the development, progression, and management of these conditions, opening new horizons for the use of dietary treatments in preventing these inflammatory conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2024
CompletedFirst Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2025
CompletedMarch 6, 2025
February 1, 2025
1.3 years
February 25, 2025
March 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3-days food diary, kidmed and medi-lite scores
After two weeks
Secondary Outcomes (1)
Percentage of families with microbiota alteration
After 6 months
Study Arms (2)
Case group
Families with at least a member affected with JIA or IBD (UC or CD)
Control group
Families with all healty components
Interventions
For each family member will be collected a 3-days food diary, a food frequencies questionnaire and a questionnaire assessing the adherence to the mediterranean diet. Additionally, a blood sample for trascriptomic analysis and a fecal sample for gut microbiota analysis will be collected
Eligibility Criteria
Cases: Families consisting of father, mother, and children aged between 0 and 18 years, in good health, with at least one member (child or adult) affected by IBD (Crohn's disease or ulcerative colitis), and families with a child affected by JIA. Controls: Healthy families consisting of father, mother, and children aged between 0 and 18 years, in good health, and not affected by chronic inflammatory bowel diseases or any chronic autoimmune inflammatory diseases.
You may qualify if:
- For families with at least one child/adult affected by IBD/JIA:
- Father and mother with children aged between 0-18 years, in good health.
- At least one adult or one child affected by IBD, or a child affected by JIA, regardless of ongoing therapy and without distinction of disease severity or activity.
- For healthy families:
- \- Father and mother with children aged between 0-18 years, in good health and not affected by chronic inflammatory bowel diseases or chronic autoimmune inflammatory diseases in general.
You may not qualify if:
- For subjects affected by IBD:
- Monogenic disease
- Children with an ileostomy or who have undergone a colectomy
- For subjects affected by JIA:
- For healthy subjects:
- \- Any chronic inflammatory bowel disease, autoimmune disease, or ongoing infectious diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
AOU Meyer IRCCS
Florence, Italy, Italy
Università La Sapienza di Roma
Roma, Roma, 00185, Italy
Università di Foggia
Foggia, Italy
Ospedale Villa Sofia Cervello, Università di Palermo
Palermo, Italy
Biospecimen
Blood samples Fecal samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 6, 2025
Study Start
February 7, 2024
Primary Completion
May 15, 2025
Study Completion
November 15, 2025
Last Updated
March 6, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share